Article
type: Class

Document
type: Class

Anualidad
type: Class

Academic Article
type: Class

Information Content Entity
type: Class

Continuant
type: Class

2022
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

individual
type: Document
rights: termsOfUse
date: 2026-08-02T05:58:29
publisher: . Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)
label: RDF description of . Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57) - http://research.umh.es/vivo/pub/articulo/235618

. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)
type: Continuant
most specific type: Academic Article
ARG_2000028: 235618 vcard
type: Entity
most specific type: 2022
type: Article
page start: 1
type: 2022
type: Generically Dependent Continuant
type: Document
has publication venue: OPEN FORUM INFECTIOUS DISEASES
type: Academic Article
type: Information Content Entity
included: Medicina Clínica 2022
related by: Autor:36736-Artículo:235618
type: Thing
type: Anualidad
date time value: 235618 pubdate
page end: 9

OPEN FORUM INFECTIOUS DISEASES
type: Journal
publication venue for: . Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)
type: Collection
type: Thing
type: Continuant
type: Periodical
type: Entity
type: Generically Dependent Continuant
type: Information Content Entity

Medicina Clínica 2022
type: 2022
type: Anualidad
type: DepartmentReport
type: Thing
type: ResearchReport
includes: . Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

Autor:36736-Artículo:235618
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: . Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)